# Dolutegravir Plus Lamivudine Simplified Therapy

> **NCT03884673** · — · RECRUITING · sponsor: **Guangzhou 8th People's Hospital** · enrollment: 300 (estimated)

## Conditions studied

- HIV/AIDS

## Interventions

- **DRUG:** DTG+ 3TC

## Key facts

- **NCT ID:** NCT03884673
- **Lead sponsor:** Guangzhou 8th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-09-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03884673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03884673, "Dolutegravir Plus Lamivudine Simplified Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03884673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*